A

nd so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, once again, rather modest. We plan to catch up on all sorts of reading, hang with our short person, and forage for valuable sonic treasures at a downsizing event. And what about you? It is never too late to plan a winter break. You might want to catch up on some of those moving pictures you meant to see. Or you could spend all weekend preparing for that football game. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The Philippine government believes that the Sanofi (SNY) dengue vaccine may be connected to three deaths in the country, The Asahi Shimbun writes. Sanofi revealed in November that Dengvaxia, the world’s first dengue vaccine, might increase the risk of severe disease in people who had never been exposed to the virus. Some experts believe at least one other vaccine, which is being developed by Takeda Pharmaceuticals (TKPYY), may see a similar problem when results of its ongoing, eight-country Phase 3 trial are available, STAT explains.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • I have sign up more the once why do USD to sing up so many times. I. Like reading your news I just tone like singing up to menu time’s. Your Friend Rose Dolan.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.